These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Catalytic heterogenity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus.
    Author: Andrievskaya OA, Buneva VN, Naumov VA, Nevinsky GA.
    Journal: Med Sci Monit; 2000; 6(3):460-70. PubMed ID: 11208354.
    Abstract:
    Various catalytically active IgG antibodies or abzymes have been detected recently in the sera of patients with several autoimmune pathologies including systemic lupus erythematosus (SLE), where their presence is most probably associated with autoimmunization. Here we show for the first time that IgM from peripheral blood of patients with SLE possesses both DNase and RNase activities: these activities were also present in Fab fragments of the IgM. Both specific enzymic activities of IgM from sera of any single patient are usually 5-10 times higher than those of IgG antibodies. The same preparations of IgM hydrolyze RNA about two order of magnitude faster than DNA. The properties of the RNases of IgM and IgG distinguished them from other known pancreatic and human sera RNases. In addition, the specific activities of the RNase activity of polyclonal IgM with the polymer substrates [RNA > poly(U) > or = poly(A) >> poly(C)], the observed range of optimal pHs, of apparent Km values for substrates and of substrate specificities varied very much for different patients. The findings speak in favor of the generation of a relatively small or an extremely large pool of polyclonal catalytic IgM by the immune system of individual patients.
    [Abstract] [Full Text] [Related] [New Search]